The sustainable way to resolve the burden of chronic diseases is prevention. Nightingale's blood analysis platform enables early disease risk prediction at both the individual and population level.
Preventive healthcare for everyone
Actionable personalized medicine
Current risk models are typically based on a limited number of measurements, leading to a “one-size-fits-all” approach that can be costly and fail patients. Healthcare experts widely acknowledge that there now needs to be a shift towards personalized medicine. Our blood analysis platform has the ability to stratify patients, taking into account the individual differences in phenotype, a crucial next step towards achieving a more personalized approach.
With our blood analysis platform, physicians will be able to identify, follow up, and reclassify patients with greater accuracy according to their individual disease risk. The ability to utilize health information in real-time will liberate physicians to provide more personalized guidance to patients and improve the effectiveness of treatment interventions - a true healthcare revolution.
Empowering patients to take control
Chronic diseases typically develop without symptoms resulting in heavy burdens for both patients and healthcare systems. Sufferers of chronic diseases can struggle with disease management and their progression can lead to severe complications.
Our blood analysis platform enables early identification of disease risk, which can be used to track the effects of lifestyle and diet interventions at an individual level. By enabling early identification of the onset of chronic diseases, we can empower patients to take control over their own health. We believe that a proactive approach that combines the efforts of patients and healthcare providers will solve the world's number one health problem - the burden of chronic diseases.
Population-level health screening
The ability to track health at both the molecular and population level provides transformative possibilities for governments to build effective nationwide health policies. With our blood analysis platform, the success of a health policy can be evaluated within months or years, rather than by decades. Rapid and accurate risk profiling predicts health outcomes and allows responsive feedback on the effect of intervention strategies, reducing the enormous cost burden chronic diseases currently have on national health budgets.
Realizing preventive healthcare
Nightingale's blood analysis platform will be introduced to the clinical market in 2017. The risk prediction power of our biomarker panel will continue to improve as we include additional biomarkers and build novel risk scores based on our strong evidence base from large population cohorts.
Stay in the know!
Subscribe to our newsletter